The latest biotech news

News and Trends 29 Apr 2022

Denmark Recruits Lifebit to Boost Personalized Medicine with Genomics

The Danish National Genome Center has teamed up with the UK firm Lifebit to improve the access and sharing of genomic data as the nation moves towards the adoption of personalized medicine. Personalized medicine is capturing the attention of healthcare authorities across the world. By harvesting genome sequences from patient populations, researchers can mine vast […]

April 29, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 28 Apr 2022

OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B

The UK firm OMass Therapeutics has unveiled a €90M (£75.5M) Series B financing to bankroll the development of small molecules against so-called ‘undruggable’ targets, including one that sank Quench Bio last year. In 2020, Quench Bio captured the imagination of investors with the US firm’s ambition to develop a new class of anti-inflammatory drugs. The […]

April 28, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 27 Apr 2022

Cancer Research UK Deploys €700M to Foster Oncology Startups

In a show of strength after an income squeeze during the Covid-19 pandemic, the charity Cancer Research UK has dedicated €711M (£600M) to setting up a new innovation arm and seed fund designed to speed up the commercialization of oncology innovation. For decades, Cancer Research UK (CRUK) has played a pivotal role in nurturing advances […]

April 27, 2022 - 4 minutesmins - By Jonathan Smith

cardiovascular disease heart attack forcefield therapeutics

News and Trends 25 Apr 2022

Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs

The startup Forcefield Therapeutics has been unveiled in the UK with €6M (£5.5M) backing from the investment firm Syncona. The mission is to develop the first drugs to safeguard heart muscle from damage during heart attacks. A sudden heart attack, also known as acute myocardial infarction, happens when the flow of blood to the heart […]

April 25, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 22 Apr 2022

European Biotech Investors Brace for Volatility in 2022

After gathering huge investment funds in 2021, European biotech investors took a breather in the first quarter of 2022, with the plan to steadily fund private biotechs amid a tumultuous public market. The last two years have seen a record-breaking amount of money flowing to biotech investors, with almost €10B reaching European life science funders […]

April 22, 2022 - 4 minutesmins - By Jonathan Smith

News and Trends 20 Apr 2022

Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights

A Covid-19 vaccine developed by the French company Valneva has received the green light from the UK’s drug regulator. The EMA, meanwhile, is proving harder to convince. The UK’s relationship with the French vaccine developer Valneva has run hot and cold over the past two years. In 2020, the UK government invested in Valneva’s manufacturing […]

April 20, 2022 - 4 minutesmins - By Jonathan Smith

finance top biotech investment March 2022

News and Trends 11 Apr 2022

The Top European Biotech Investments in March 2022

As wars and inflation buffet European markets, private biotech companies raised fewer investments in March 2022 than in previous months. The top private rounds went to firms developing cancer treatments and microbiome therapeutics. The first quarter of 2022 has seen a gradual decline of biotech investments in the European space. The total raised by European […]

April 11, 2022 - 5 minutesmins - By Jonathan Smith

UK kynos epidarex anti inflammatory drugs

News and Trends 8 Apr 2022

Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs

The UK-US venture capitalist Epidarex Capital has led an €11M (£9M) funding round raised by the Edinburgh-based Kynos Therapeutics, which aims to develop anti-inflammatory treatments by blocking an emerging metabolic target. Much of the UK’s biotech innovation is concentrated in the so-called Golden Triangle, encompassing the hubs of Cambridge, Oxford, and London. In 2020, Epidarex […]

April 8, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 6 Apr 2022

Immunocore Approvals Open Door for TCR Cancer Drugs

The EU has followed the FDA in granting market approval to Kimmtrak, the first-ever bispecific drug based on a cancer-hunting protein called a T-cell receptor (TCR). These regulatory wins by the UK firm Immunocore pave the way for other treatments deploying TCRs. TCRs have become a hot topic in immuno-oncology. Many companies are developing cancer […]

April 6, 2022 - 3 minutesmins - By Jonathan Smith

world health organization genomics pathogen pandemic

News and Trends 5 Apr 2022

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

The World Health Organization has released a 10-year plan to monitor the genetic make-up of pathogens across the globe. The strategy highlights how far genomics has come during the Covid-19 pandemic and how far there is to go. The past two years have seen unprecedented global collaboration as researchers raced to better understand the epidemiology, […]

April 5, 2022 - 4 minutesmins - By Anita Chakraverty

News and Trends 1 Apr 2022

Europe Shuns Russian Covid-19 Vaccines as Ukraine War Continues

In the last two years, Russian Covid-19 vaccine makers had a tough time penetrating the European market with their flagship vaccine, Sputnik V. This year, Russia’s invasion of Ukraine has likely dashed Sputnik V’s chances of reaching Europe anytime soon. Just months after the Covid-19 pandemic began, Russia was the first country to approve a […]

April 1, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 31 Mar 2022

Precision Medicine Startups Increase Focus on Data Access and Privacy

Low-cost genetic sequencing is becoming increasingly accessible and profitable for companies, but data protection and ownership remains a key issue for many individuals. Sano Genetics is one of many firms driving precision medicine by creating a more mutually beneficial relationship between patients and pharma companies. The falling costs of DNA sequencing are leading to serious […]

March 31, 2022 - 4 minutesmins - By Anita Chakraverty

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

Denmark Recruits Lifebit to Boost Personalized Medicine with Genomics

OMass Therapeutics Takes on ‘Undruggable’ Proteins with €90M Series B

Cancer Research UK Deploys €700M to Foster Oncology Startups

Forcefield Therapeutics Launched to Treat Heart Attacks with Protein Drugs

European Biotech Investors Brace for Volatility in 2022

Valneva’s Covid-19 Vaccine Reaches UK Market with EU In Sights

The Top European Biotech Investments in March 2022

Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs

Immunocore Approvals Open Door for TCR Cancer Drugs

WHO Beefs up Worldwide Genomic Surveillance to Prevent Pandemics

Europe Shuns Russian Covid-19 Vaccines as Ukraine War Continues

Precision Medicine Startups Increase Focus on Data Access and Privacy

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!